Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06305702
Status:
COMPLETED
Last Update Posted:
2024-03-12
First Post:
2024-03-05
Brief Title:
Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer
Sponsor:
Organization:
Liaoning Tumor Hospital Institute